OPA1, a new mitochondrial target in cancer therapy
Stephanie Herkenne1,Department of Biology, University of Padova, Padova, Italy2,Veneto Institute of Molecular Medicine, Padova, Italy3Interdisciplinary Cluster in Applied Genoproteomics (GIGA) Research Center, University of Liège, Liège, Belgium, Luca Scorrano1,Department of Biology, University of Padova, Padova, Italy2Veneto Institute of Molecular Medicine, Padova, Italy
1Department of Biology, University of Padova, Padova, Italy
2Veneto Institute of Molecular Medicine, Padova, Italy
3Interdisciplinary Cluster in Applied Genoproteomics (GIGA) Research Center, University of Liège, Liège, Belgium
Received: September 27, 2020Accepted: October 5, 2020Published: November 13, 2020